These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 37255714)

  • 1. A new perspective on Alzheimer's disease: m6A modification.
    Xia L; Zhang F; Li Y; Mo Y; Zhang L; Li Q; Luo M; Hou X; Du Z; Deng J; Hao E
    Front Genet; 2023; 14():1166831. PubMed ID: 37255714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential methylation of circRNA m6A in an APP/PS1 Alzheimer's disease mouse model.
    Zhang X; Yang S; Han S; Sun Y; Han M; Zheng X; Li F; Wei Y; Wang Y; Bi J
    Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36660942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.
    Tang Z; Cao J; Yao J; Fan X; Zhao J; Zhao M; Duan Q; Han B; Duan S
    Free Radic Biol Med; 2023 Feb; 195():343-358. PubMed ID: 36587923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Expression of the m6A Methyltransferase METTL3 in Alzheimer's Disease.
    Huang H; Camats-Perna J; Medeiros R; Anggono V; Widagdo J
    eNeuro; 2020; 7(5):. PubMed ID: 32847866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormality of m6A mRNA Methylation Is Involved in Alzheimer's Disease.
    Han M; Liu Z; Xu Y; Liu X; Wang D; Li F; Wang Y; Bi J
    Front Neurosci; 2020; 14():98. PubMed ID: 32184705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification.
    Li M; Cheng W; Zhang L; Zhou C; Peng X; Yu S; Zhang W
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer's Disease.
    Weng S; Lai QL; Wang J; Zhuang L; Cheng L; Mo Y; Liu L; Zhao Z; Zhang Y; Qiao S
    Front Aging Neurosci; 2022; 14():899944. PubMed ID: 35837481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders.
    Lei C; Wang Q
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
    Bowirrat A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and ischemic stroke.
    Zhang F; Ran Y; Tahir M; Li Z; Wang J; Chen X
    Front Cell Neurosci; 2022; 16():955222. PubMed ID: 35990887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiology of Alzheimer's disease.
    Mohandas E; Rajmohan V; Raghunath B
    Indian J Psychiatry; 2009 Jan; 51(1):55-61. PubMed ID: 19742193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyroptosis as a candidate therapeutic target for Alzheimer's disease.
    Huang Y; Li X; Luo G; Wang J; Li R; Zhou C; Wan T; Yang F
    Front Aging Neurosci; 2022; 14():996646. PubMed ID: 36185484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.
    Yang Y; Zhang Z
    Front Aging Neurosci; 2020; 12():110. PubMed ID: 32477095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Genomic Analysis of m6a-SNPs Identifies Potential Functional Variants Associated with Alzheimer's Disease.
    Jan SM; Fahira A; Shi Y; Khan MI; Jamal A; Mahmood A; Shams S; Parveen Z; Hu J; Umair M; Wadood A
    ACS Omega; 2023 Apr; 8(14):13332-13341. PubMed ID: 37065064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic, Cell-Derived, Brain-Derived, and Recombinant β-Amyloid: Modelling Alzheimer's Disease for Research and Drug Development.
    Varshavskaya KB; Mitkevich VA; Makarov AA; Barykin EP
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.